[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Idexx Laboratories (IDXX)

Idexx Laboratories (IDXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 44,452,944
  • Shares Outstanding, K 78,883
  • Annual Sales, $ 4,304 M
  • Annual Income, $ 1,059 M
  • EBIT $ 1,406 M
  • EBITDA $ 1,551 M
  • 60-Month Beta 1.58
  • Price/Sales 10.41
  • Price/Cash Flow 37.65
  • Price/Book 28.99

Options Overview Details

View History
  • Implied Volatility 32.44% (+0.51%)
  • Historical Volatility 30.74%
  • IV Percentile 53%
  • IV Rank 40.68%
  • IV High 49.02% on 01/30/26
  • IV Low 21.07% on 08/12/25
  • Expected Move (DTE 19) 30.87 (5.48%)
  • Put/Call Vol Ratio 2.14
  • Today's Volume 66
  • Volume Avg (30-Day) 107
  • Put/Call OI Ratio 0.61
  • Today's Open Interest 2,030
  • Open Int (30-Day) 2,015
  • Expected Range 532.66 to 594.40

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $3.94
  • Number of Estimates 7
  • High Estimate $4.03
  • Low Estimate $3.81
  • Prior Year $3.63
  • Growth Rate Est. (year over year) +8.54%

Price Performance

See More
Period Period Low Period High Performance
1-Month
523.38 +7.67%
on 05/13/26
585.12 -3.69%
on 05/07/26
+9.87 (+1.78%)
since 04/29/26
3-Month
523.38 +7.67%
on 05/13/26
651.06 -13.44%
on 03/04/26
-93.20 (-14.19%)
since 02/27/26
52-Week
504.56 +11.69%
on 06/02/25
769.98 -26.81%
on 11/26/25
+49.20 (+9.57%)
since 05/28/25

Most Recent Stories

More News
Is Wall Street Bullish or Bearish on IDEXX Laboratories Stock?

Although IDEXX Laboratories has lagged the broader market over the past year, Wall Street analysts remain fairly bullish about the company’s long-term growth prospects.

XHE : 79.49 (-1.07%)
$SPX : 7,580.06 (+0.22%)
IDXX : 563.53 (-0.79%)
IDEXX Expands Fecal Dx Antigen Testing Platform with Taeniid Tapeworm Detection

Third menu expansion in four years broadens intestinal parasite detection in routine care

IDXX : 563.53 (-0.79%)
IDEXX SDMA Now Integrated into the Most Common Catalyst Chemistry Profiles

Built-in SDMA delivers earlier insights with seamless workflow

IDXX : 563.53 (-0.79%)
The Biology Came First.

Over 20 partner-owned drug programs have reached clinical trials as a result of antibody discovery work performed by MindWalk scientists — ten currently in active Phase 1–3. The same scientific depth...

CGEM : 16.44 (+7.03%)
IDXX : 563.53 (-0.79%)
IPA : 2.07 (+7.25%)
ARGX : 835.99 (-0.30%)
XNCR : 11.88 (-0.75%)
HYFT : 1.7600 (-1.68%)
IDEXX Laboratories to Present at Stifel Conference and Announces 2026 Investor Day

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced that Mike Erickson, President and Chief Executive Officer, will participate in a fireside chat at...

IDXX : 563.53 (-0.79%)
Idexx: Q1 Earnings Snapshot

Idexx: Q1 Earnings Snapshot

IDXX : 563.53 (-0.79%)
IDEXX Laboratories Announces First Quarter Results

Achieves first quarter revenue growth of 14% as reported and 11% organic, and CAG Diagnostics recurring revenue growth of 14% as reported and 11% organic. ...

IDXX : 563.53 (-0.79%)
IDEXX Laboratories Set to Reveal Whether Veterinary Diagnostics Momentum Can Justify Premium Valuation

Barchart Research What to Expect from IDXX Earnings IDXX Generated May 4, 2026 Current Price $563.12 EPS Estimate $$3.42 Consensus Rating Moderate Buy Average Move 10.62% IDEXX Laboratories Set to Reveal...

IDXX : 563.53 (-0.79%)
What You Need to Know Ahead of IDEXX Laboratories' Earnings Release

IDEXX Laboratories is ready to release its fiscal first-quarter earnings next month, and analysts project a double-digit profit growth.

XLV : 149.47 (-0.93%)
$SPX : 7,580.06 (+0.22%)
IDXX : 563.53 (-0.79%)
IDEXX Laboratories to Release 2026 First Quarter Financial Results

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2026 first quarter financial results for Tuesday, May 5, 2026, before the...

IDXX : 563.53 (-0.79%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

IDEXX Laboratories, Inc. is a developer, manufacturer and distributor of products and services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The company also sells a series of portable electrolytes and blood gas analyzers for the human point-of-care...

See More

Key Turning Points

3rd Resistance Point 580.99
2nd Resistance Point 577.24
1st Resistance Point 570.39
Last Price 563.53
1st Support Level 559.78
2nd Support Level 556.03
3rd Support Level 549.18

See More

52-Week High 769.98
Fibonacci 61.8% 668.59
Fibonacci 50% 637.27
Fibonacci 38.2% 605.95
Last Price 563.53
52-Week Low 504.56

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.